Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...

A 5,000-mile service alert raised questions, and we still can’t prove who made the change.

Foundry Robotics raised a $100M oversubscribed Series A led by Marlinspike Partners to build an AI-powered autonomous ...

A new review proposes an immunometabolic framework for paediatric refractory Mycoplasma pneumoniae pneumonia, while stressing ...

In patients aged 64+: 79.2% of patients achieved a clinically meaningful response (reduced pain and improved knee function) in the Allocetra™ group vs. 47.6% in the placebo group at 12 months (p=0.027 ...

A seven-cohort single-cell atlas links early-onset colorectal cancer to coordinated epithelial, stromal and NOTCH-associated ...

Science is advancing like never before. While we, common folk, have seen technology evolve way too fast in the last 30 years, ...

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

AOA Dx Chief Scientific Officer Abby McElhinny discusses with LCGC International how the company used high-resolution mass spectrometry-based multi-omics to develop Omira OC, a targeted blood test for ...

Feasibility and innate-to-Th1 pharmacodynamics for candidate OAP-101, built on proprietary OmniAntigen™ Platform (OAP) OAP ...

Profiles Retro Biosciences, Altos Labs, NewLimit, Life Biosciences and Serina Therapeutics, covering their epigenetic reprogramming longevity therapies.Dublin, Oct. (GLOBE NEWSWIRE) -- "Epigenetic ...